🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

J&J to buy remaining stake in Verb Surgical to strengthen digital surgery portfolio

Published 2019-12-20, 07:53 a/m
© Reuters. The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the NYSE in New York
GOOGL
-
JNJ
-
GOOG
-

(Reuters) - Johnson & Johnson (NYSE:JNJ) said on Friday it would acquire the remaining stake in Verb Surgical Inc, from Verily, Alphabet (NASDAQ:GOOGL) Inc's life sciences division.

Bolstering its Ethicon unit, which makes surgical equipment, J&J in 2015 formed an independent company called Verb Surgical with Verily to create smaller, smarter and less costly robotic-assisted systems for surgery. (https://reut.rs/2EBtI9j)

The deal for Verb Surgical is expected to close in the first half of 2020, J&J said without disclosing deal terms.

J&J pushed further into the surgical robotics space with its $3.4-billion acquisition of Auris Health Inc earlier this year. The deal gave J&J access to the privately held company's surgical robotic scope used in respiratory procedures and the detection of lung cancer.

© Reuters. The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the NYSE in New York

The acquisition of Auris accelerated J&J's entry into digital surgery, kicking off a strong pipeline of launches that will take place over the next several years, J&J said on Friday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.